| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2025 ( Subtotal = $86,989 ) |
| 2025 | 2025 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | K23DK128561 | Developing a Behavioral Weight Loss Intervention for Emerging Adults Implemented within College Health Service Centers | 000 | 4 | NIH | 11/13/2024 | $188,244 |
| 2025 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | K24AI134359 | HIV drug resistance, monitoring and transmission | 001 | 6 | NIH | 11/13/2024 | $63,558 |
| 2025 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | T32HL076134 | Training in Behavioral and Preventative Medicine | 000 | 17 | NIH | 10/18/2024 | $0 |
| 2025 | 2022 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | K24AI134359 | HIV drug resistance, monitoring and transmission | 000 | 5 | NIH | 11/13/2024 | -$63,558 |
| 2025 | 2022 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | K08HL145075 | Impact of Dysfunctional HDL on Platelet Function and in vivo Thrombosis | 001 | 5 | NIH | 10/30/2024 | $29 |
| 2025 | 2022 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | R01HS026895 | Optimizing Antimicrobial Use in Maintenance Dialysis Units (OPTIMUS) | 000 | 4 | AHRQ | 10/24/2024 | $0 |
| 2025 | 2021 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | R01MH114657 | Characterizing the HIV pre-exposure prophylaxis care continuum for African American and Hispanic/Latino men who have sex with men | 000 | 5 | NIH | 11/8/2024 | -$101,284 |
|
| Issue Date FY: 2024 ( Subtotal = $20,482,491 ) (Continued on the next page) |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 004 | 26 | NIH | 9/9/2024 | $0 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 004 | 26 | NIH | 9/9/2024 | $0 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 004 | 26 | NIH | 9/9/2024 | $0 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 004 | 26 | NIH | 9/9/2024 | $0 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 004 | 26 | NIH | 9/9/2024 | $0 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 004 | 26 | NIH | 9/9/2024 | $0 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 004 | 26 | NIH | 9/9/2024 | $0 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 004 | 26 | NIH | 9/9/2024 | $0 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 004 | 26 | NIH | 9/9/2024 | $0 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | R01AI186632 | HIV Drug Resistance in the New Antiretroviral Therapy Era in Kenya | 000 | 1 | NIH | 9/12/2024 | $645,900 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | R01DA059503 | A multidisciplinary approach to integrate HIV prevention services into clinical care settings for people with opioid use disorder | 001 | 1 | NIH | 9/20/2024 | $0 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P20GM139767 | COBRE for Stress, Trauma and Resilience (STAR) | 002 | 4 | NIH | 8/28/2024 | $2,206,835 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | K08DA056697 | Childhood adversity and substance use: Integrating laboratory and ecological approaches to understand the role of affect | 000 | 3 | NIH | 8/13/2024 | $185,439 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | R01HL171158 | An Application of SMART Methodology to Optimize an Intervention to Maintain Improvements in Health Behaviors in Under-resourced Patients after Phase II Cardiac Rehabilitation | 000 | 1 | NIH | 8/6/2024 | $540,798 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | R01HL171158 | An Application of SMART Methodology to Optimize an Intervention to Maintain Improvements in Health Behaviors in Under-resourced Patients after Phase II Cardiac Rehabilitation | 000 | 1 | NIH | 8/6/2024 | $200,000 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | T32HL076134 | Training in Behavioral and Preventative Medicine | 004 | 17 | NIH | 8/23/2024 | $33,690 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 002 | 26 | NIH | 8/1/2024 | $160,000 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 002 | 26 | NIH | 8/1/2024 | $214,000 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 002 | 26 | NIH | 8/1/2024 | $118,365 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 002 | 26 | NIH | 8/1/2024 | $41,400 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 002 | 26 | NIH | 8/1/2024 | $738,351 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 002 | 26 | NIH | 8/1/2024 | $45,400 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 002 | 26 | NIH | 8/1/2024 | $41,400 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 002 | 26 | NIH | 8/1/2024 | $41,400 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 002 | 26 | NIH | 8/1/2024 | $45,400 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 002 | 26 | NIH | 8/1/2024 | $41,400 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 002 | 26 | NIH | 8/1/2024 | $143,500 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 002 | 26 | NIH | 8/1/2024 | $68,500 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | R01DK137759 | Comparison of behaviorally-based remote approaches to optimize weight loss and identification of factors which characterize treatment response | 000 | 1 | NIH | 7/31/2024 | $631,896 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 003 | 26 | NIH | 8/2/2024 | $185,281 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | R01DK124551 | Enhancing Emotion Regulation to Support Weight Control Efforts in Adolescents with Overweight and Obesity | 000 | 5 | NIH | 7/22/2024 | $484,292 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | R01HL159204 | Differential thrombogenesis effects of EPA and DHA mediated by HDL | 001 | 2 | NIH | 6/25/2024 | $516,085 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2853 | PROVIDENCE | USA | H7600018 | Ryan White Part C Outpatient EIS Program | 01 | 31 | HRSA | 1/25/2024 | $263,736 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | H7600018 | Ryan White Part C Outpatient EIS Program | 02 | 31 | HRSA | 6/6/2024 | $329,672 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2853 | PROVIDENCE | USA | H7600018 | Ryan White Part C Outpatient EIS Program | 00 | 31 | HRSA | 11/14/2023 | $197,803 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | H7600018 | Ryan White Part C Outpatient EIS Program | 03 | 31 | HRSA | 8/6/2024 | $16,657 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | R01DK136216 | Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment | 001 | 1 | NIH | 7/15/2024 | $0 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | R01AI147333 | Addressing HIV drug resistance research gaps in a cohort of perinatally infected Kenyan children and adolescents | 000 | 5 | NIH | 6/5/2024 | $686,299 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | R01HL172869 | Mechanisms of mindfulness training to reduce maternal and infant cardiovascular disease risk | 000 | 1 | NIH | 5/3/2024 | $647,174 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | R01DK136216 | Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment | 000 | 1 | NIH | 5/14/2024 | $583,734 |
| 2024 | 2024 | THE MIRIAM HOSPITAL | 164 SUMMIT AVE | PROVIDENCE | RI | 02906-2894 | PROVIDENCE | USA | R01DA056787 | Placental Genomics in the Developmental Consequences of Marijuana Use in Pregnancy | 000 | 2 | NIH | 5/17/2024 | $642,372 |
|